Table 1.
Gene | SNP | Ngodhe island | Mfangano island | East Africa1 | West Africa2 | ||||
---|---|---|---|---|---|---|---|---|---|
MAF | 95% CI | n | MAF | 95% CI | n | MAF (n = 228) | MAF (n = 167) | ||
Pfcrt | M74I | 6.5 | 2.2–18 | 46 | 0 | 0–12 | 27 | 0 | 0 |
N75E | 4.4 | 1.5–15 | 45 | 0 | 0–12 | 27 | 0 | 0 | |
K76T | 4.4 | 1.5–15 | 45 | 7.4 | 2.1–23 | 27 | 17.5 | 13.0 | |
H97Y | 0 | 0–7.9 | 45 | 0 | 0–12 | 27 | 0 | 0 | |
Pfmdr1 | F61Y | 3.5 | 0.97–12 | 57 | 0 | 0–11 | 30 | 0 | 0 |
N86Y | 2.0 | 0.35–10 | 50 | 0 | 0–11 | 30 | 15.7 | 24.4 | |
Y184F | 47.1 | 34–60 | 51 | 31.7 | 0–11 | 30 | 39.0 | 15.5 | |
T199S | 13.5 | 6.7–25 | 52 | 3.1 | 0.55–16 | 32 | 0.01 | 0 | |
F938Y | 3.0 | 0.83–10 | 66 | 0 | 0–11 | 31 | 8.3 | 22.2 | |
F1072Y | 2.0 | 0.37–11 | 48 | 0 | 0–10 | 35 | 0 | 0 | |
D1246Y | 16.0 | 7.1–33 | 31 | 2.9 | 0.51–15 | 35 | 12.9 | 31.2 | |
Pfk13 | A578S | 3.1 | 0.83–11 | 65 | 0 | 0–10 | 35 | 1.1 | 0 |
F451Y | 4.5 | 1.6–13 | 66 | 0 | 0–10 | 35 | 0 | 0 | |
Pfdhfr | N51I | 77.0 | 62–85 | 53 | 100 | 90–100 | 34 | 91.4 | 92.5 |
C59R | 76.9 | 64–86 | 52 | 91.2 | 77–97 | 34 | 86.4 | 93.0 | |
S108N | 80.8 | 68–89 | 52 | 100 | 90–100 | 36 | 99.4 | 93.0 | |
I164L | 5.8 | 2.0–16 | 52 | 6.9 | 2.9–22 | 36 | 1.5 | 0 | |
Pfdhps | S436H | 11.9 | 5.2–25 | 42 | 22.9 | 12–39 | 35 | 0 | 0 |
G437A | 100 | 92–100 | 42 | 100.0 | 90–100 | 35 | 85.3 | 70.0 | |
K540E | 79.2 | 66–88 | 48 | 95.7 | 85–99 | 35 | 84.4 | 30.0 |
1East Africa: Kenya, Tanzania, and Uganda.
2West Africa: The Gambia and Mauritania.
bold - mutations with known resistance associations.